Eli Lilly and Company
Approved Evidence
Added to Rotten Company: 8/26/2026
Conduct/Event period: 1999–March 31, 2005
Ongoing: No
Resolution status: Resolved
Resolution date: January 15, 2009
Eli Lilly pleaded guilty and paid $1.415 billion over off-label Zyprexa promotion
Summary
Eli Lilly agreed to plead guilty and pay $1.415 billion for promoting Zyprexa for uses not approved by the FDA. The resolution included a $515 million criminal fine and up to $800 million in civil settlements. Source: https://www.justice.gov/archives/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa
Evidence Weight
100.00
Severity:
Recency Weight: 99.99989820687469
File Weight: 1